Overview and Scope
Convalescent plasma is plasma that has been collected from people who have recovered or are convalescing and contains antibodies against the infection-causing microorganism. It is used for the treatment of patients infected by the respective pathogen.
Sizing and Forecast
The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from <b>$0.05 billion in 2023 to $0.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. </b> The growth in the historic period can be attributed to pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorization (eua), patient availability, clinician and public awareness.
The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to ” <b>$0.08 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. </b> The growth in the forecast period can be attributed to evolving pathogens, immunotherapies development, regulatory frameworks, global preparedness, public health initiatives. Major trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment, telemedicine and remote monitoring, research into long-term effects.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report
Segmentation & Regional Insights
The convalescent plasma therapy market covered in this report is segmented –
1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals & Clinics, Laboratories & Research institutes
<b>North America</b> was the largest region in the convalescent plasma therapy market in 2023. <b>Western Europe</b> was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp
Major Driver Impacting Market Growth
Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period. Convalescent plasma transfusion has been of interest in the historical period for the treatment of other infectious disease outbreaks such as SARS‐1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2020, results of a study conducted by the Houston Methodist hospital, which aimed at evaluating safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe with no adverse events reported and is efficient with 76% recovery rate. In May 2020, a study published in the Journal of Medical Virology stated that with convalescent plasma therapy, the mortality rate may be reduced in critically ill patients, beneficial effects on clinical symptoms will be observed, and an increase in neutralizing antibody titers and disappearance of SARS‐CoV‐2 RNA will be observed. The safety and efficacy of the convalescent plasma therapy in COVID-19 patients will boost the global convalescent plasma therapy market growth.
Key Industry Players
Major companies operating in the convalescent plasma therapy market include <b>Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank</b>
The convalescent plasma therapy market report table of contents includes:
1. Executive Summary
2.Convalescent Plasma Therapy Market Characteristics
3.Convalescent Plasma Therapy Market Trends And Strategies
4.Convalescent Plasma Therapy Market analysis
5.Convalescent Plasma Therapy Market Size And Growth
6. Convalescent Plasma Therapy Segmentation
7.Convalescent Plasma Therapy Regional And Country Analysis
.
.
.
27.Convalescent Plasma Therapy Competitive Landscape And Company Profiles
28.Convalescent Plasma Therapy Key Mergers And Acquisitions
29.Convalescent Plasma Therapy Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Bio Farma
- Hilton Pharma Ltd.
- Biotest AG, BPL Ltd.
- LFB SA
- Octapharma AG
- CSL Behring LLC
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
